Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts | Journal of Medicinal Chemistry
![Pharmaceutics | Free Full-Text | Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy Pharmaceutics | Free Full-Text | Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-02706/article_deploy/html/images/pharmaceutics-14-02706-g001.png)
Pharmaceutics | Free Full-Text | Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy
![Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets | Journal of Medicinal Chemistry Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b00935/asset/images/large/jm-2016-00935d_0025.jpeg)
Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets | Journal of Medicinal Chemistry
![Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB | Journal of Pharmacology and Experimental Therapeutics Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/sites/default/files/highwire/jpet/382/3.cover-source.jpg)
Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB | Journal of Pharmacology and Experimental Therapeutics
![PDF) National Toxicology Program Position Statement on Informed (“Nonblinded”) Analysis in Toxicologic Pathology Evaluation PDF) National Toxicology Program Position Statement on Informed (“Nonblinded”) Analysis in Toxicologic Pathology Evaluation](https://i1.rgstatic.net/publication/335837341_National_Toxicology_Program_Position_Statement_on_Informed_Nonblinded_Analysis_in_Toxicologic_Pathology_Evaluation/links/60a2b9e7299bf1b014ff0500/largepreview.png)